Ethic Inc’s Krystal Biotech KRYS Stock Holding History

Ethic Inc’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$301K	Buy	1,166 +203	+21%	+$54K	﹤0.01%	1035
2025 Q4	$237K	Buy	+963	New	+$203K	﹤0.01%	1085
2025 Q2	–	Sell	-1,431	Closed	-$250K	–	1265
2025 Q1	$250K	Buy	+1,431	New	+$241K	0.01%	1005
2024 Q4	–	Sell	-1,142	Closed	-$203K	–	1191
2024 Q3	$203K	Sell	1,142 -131	-10%	-$25.3K	0.01%	1004
2024 Q2	$234K	Buy	1,273 +131	+11%	+$22K	0.01%	980
2024 Q1	$203K	Sell	1,142 -516	-31%	-$71.7K	0.01%	1003
2023 Q4	$206K	Sell	1,658 -185	-10%	-$20.5K	0.01%	978
2023 Q3	$214K	Sell	1,843 -475	-20%	-$58K	0.01%	916
2023 Q2	$272K	Buy	+2,318	New	+$237K	0.01%	819
2023 Q1	–	Sell	-2,629	Closed	-$208K	–	987
2022 Q4	$208K	Buy	+2,629	New	+$195K	0.01%	819

Other funds holding KRYS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return